![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » UK Secures 90 Million Doses of COVID-19 Vaccine from Pfizer, BioNTech and Valneva
UK Secures 90 Million Doses of COVID-19 Vaccine from Pfizer, BioNTech and Valneva
![UKflag.jpg](https://www.fdanews.com/ext/resources/test/Drug-Images4/UKflag.jpg?t=1586293848&width=430)
The UK has secured 90 million doses of COVID-19 vaccines from Pfizer, BioNTech and French drugmaker Valneva.
Pfizer and BioNTech will provide 30 million doses of its mRNA-based COVID-19 vaccine. Valneva will provide 60 million doses of its inactivated vaccine candidate and could provide an additional 40 million doses.
The UK has also secured COVID-19 neutralizing antibodies from AstraZeneca for people who cannot tolerate vaccines.
Upcoming Events
-
21Oct